Abstract
The effect of levamisole (LMS) on T-cell-mediated antitumor immunity was examined in adult and aged mice hyperimmune to L1210 leukemia. The immune resistance of aged mice was depressed compared with that of adult mice, which almost completely rejected 5×107 L1210 cells inoculated IP. A significant level of tumor-specific cytotoxicity was detected in the spleen cells of adult hyperimmune mice by the 51Cr-release assay after in vitro sensitization with mitomycin C-treated L1210 cells. This was mediated by cytotoxic T cells, since in vivo administration of antithymocyte serum or in vitro treatment of the spleen cells with anti-Thy 1.2 antibody and complement abrogated the cytotoxicity completely. In aged mice, however, cytotoxic T-cell activity was lower although the animals were immune to L1210.
Administration of LMS (0.38 mg/kg) restored the depressed cytotoxicity of aged mice to the level seen in adult mice. Furthermore, in adult hyperimmune mice LMS augmented T-cell-mediated cytotoxic activity and restored the reduced cytotoxicity caused by in vivo administration of antithymocyte serum. These results indicate that LMS was effective in augmenting T-cell-mediated tumor immunity in immunologically competent or deficient hosts.
Keywords: Leukemia, Cytotoxic Activity, Adult Mouse, Mitomycin, Spleen Cell
References
- 1.Abraham C, Tal Y, Gershon H. Reduced in vitro response to concanavalin A and lipopolysaccharide in senescent mice: a function of reduced number of responding cells. Eur J Immunol. 1977;7:301. doi: 10.1002/eji.1830070512. [DOI] [PubMed] [Google Scholar]
- 2.Berd D, Prehn RT. Peritoneal macrophage response to leukemia L1210 in syngeneic mice. J Natl Cancer Inst. 1977;58:1729. doi: 10.1093/jnci/58.6.1729. [DOI] [PubMed] [Google Scholar]
- 3.Bruley-Rosset M, Florentin I, Kiger N, Davigny M, Mathé G. Effects of Bacillus Calmette-Guérin and levamisole on immune responses in young adult and age-immunodepressed mice. Cancer Treat Rep. 1978;62:1641. [PubMed] [Google Scholar]
- 4.Brunner KT, Mauel J, Rudolf H, Chapuis B. Studies of allograft immunity in mice. I. Induction, development and in vitro assay of cellular immunity. Immunology. 1970;18:501. [PMC free article] [PubMed] [Google Scholar]
- 5.Callard RE, Basten A. Immune function in aged mice. I. T-cell responsiveness using phytohaemagglutinin as a functional probe. Cell Immunol. 1977;31:13. doi: 10.1016/0008-8749(77)90002-8. [DOI] [PubMed] [Google Scholar]
- 6.Geran RI, Greenberg NH, Macdonald MM, Schumacher AM, Abbott BJ. Protocols for screening chemical agents and natural products against animal tumors and other biological system. Cancer Chemother Rep [III] 1972;3:1. [Google Scholar]
- 7.Hirano T, Nordin AA. Age-associated decline in the in vitro development of cytotoxic lymphocytes in NZB mice. J Immunol. 1976;117:1093. [PubMed] [Google Scholar]
- 8.Kataoka T, Oh-hashi F, Tsukagoshi S, Sakurai Y. Induction of resistance to L1210 leukemia in Balb/c × DBA/2CrF1 mice with L1210 cells treated with glutaraldehyde and concanavalin A. Cancer Res. 1977;37:964. [PubMed] [Google Scholar]
- 9.Kataoka T, Oh-hashi F, Sakurai Y. Immunotherapeutic response of concanavalin A-bound L1210 vaccine enhanced by a streptococcal immunopotentiator, OK-432. Cancer Res. 1979;39:2807. [PubMed] [Google Scholar]
- 10.Kataoka T, Oh-hashi F, Sakurai Y, Okabe M, Gomi K. Factors responsible for immune resistance to L1210 murine leukemia in hyperimmune mice. Cancer Immunol Immunother. 1979;7:123. doi: 10.1007/BF00205485. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Kataoka T, Tsukagoshi S, Sakurai Y, Okabe M. Potentiation of L1210 murine leukemia vaccine in vivo by levamisole. Gann. 1979;70:515. [PubMed] [Google Scholar]
- 12.Krogsrud RL, Perkins EH. Age-related changes in T cell function. J Immunol. 1977;118:1607. [PubMed] [Google Scholar]
- 13.Mihich E. Combined effects of chemotherapy and immunity against leukemia L1210 in DBA/2 mice. Cancer Res. 1969;29:848. [PubMed] [Google Scholar]
- 14.Miller FR, Heppner GH. Assessment of syngeneic cell-mediated immunity to mouse mammary tumors by three different assays. Cancer Immunol Immunother. 1979;7:77. [Google Scholar]
- 15.Morimoto C, Abe T, Homma M. Restoration of T-cell function in aged mice with long-term administration of levamisole. Clin Immunol Immunopathol. 1979;12:316. doi: 10.1016/0090-1229(79)90034-5. [DOI] [PubMed] [Google Scholar]
- 16.Ramot B, Biniaminov M, Shoham C, Rosenthal E. Effect of levamisole on E-rosette-forming cells in vivo and vitro in Hodgkin's disease. N Engl J Med. 1976;294:809. doi: 10.1056/NEJM197604082941504. [DOI] [PubMed] [Google Scholar]
- 17.Renoux G, Renoux M. Thymus-like activities of sulphur derivatives on T-cell differentiation. J Exp Med. 1977;145:466. doi: 10.1084/jem.145.2.466. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Sampson D, Lui A. The effect of levamisole on cell-mediated immunity and suppressor cell function. Cancer Res. 1976;36:952. [PubMed] [Google Scholar]
- 19.Sethi KK, Brandis H. Neuraminidase-induced loss in the transplantability of murine leukemia L1210, induction of immunoprotection and the transfer of induced immunity to normal DBA/2 mice by serum and peritoneal cells. Br J Cancer. 1973;27:106. doi: 10.1038/bjc.1973.14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Shigemoto S, Kishimoto S, Yamamura Y. Change of cell-mediated cytotoxicity with aging. J Immunol. 1975;115:307. [PubMed] [Google Scholar]
- 21.Skipper HE. Cellular kinetics associated with “curability” of experimental leukemias. In: Dameshek W, Dutcher RM, editors. Perspectives in leukemia. New York: Grune and Stratton; 1968. p. 187. [Google Scholar]
- 22.Smith KA, Gillis S, Ruscetti FW, Baker PE, McKenzie D. T-cell growth factor: the second signal in the T-cell immune response. Ann NY Acad Sci. 1980;332:423. doi: 10.1111/j.1749-6632.1979.tb47136.x. [DOI] [PubMed] [Google Scholar]